| Michael Howard Siev, MD | |
|
20 York St, New Haven, CT 06510-3220 | |
| (203) 688-4242 | |
| Not Available |
| Full Name | Michael Howard Siev |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 8 Years |
| Location | 20 York St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093161895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 67241 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Manchester Memorial Hospital | Manchester, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
A team of researchers from Harvard School of Public Health (HSPH), Brigham and Women's Hospital (BWH), and elsewhere have described a possible reason why some studies have been unable to replicate associations between genes and traits - namely that the strength of a gene/trait association might vary with age and that current study designs typically fail to take that into account.
New research published this month in the Southern Economic Journal reveals job losses during the Great Recession (2007-2009) may be partly responsible for the recent drop in U.S. birth rates.
Tetraphase Pharmaceuticals, a clinical stage biopharmaceutical company utilizing breakthrough synthetic chemistry technology to discover and develop next-generation antibiotics, today announced that it has raised $45 million in a Series C financing.
The Biotechnology and Biological Sciences Research Council (BBSRC) has awarded a grant of over £0.5 million to groups in the Laboratories for Integrative Neuroscience and Endocrinology and the MRC Centre for Synaptic Plasticity (project leader, Professor Kei Cho). The funding will support research into how brain cells maintain their performance, and create memories, during periods of acute stress.
› Verified 6 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A team of researchers from Harvard School of Public Health (HSPH), Brigham and Women's Hospital (BWH), and elsewhere have described a possible reason why some studies have been unable to replicate associations between genes and traits - namely that the strength of a gene/trait association might vary with age and that current study designs typically fail to take that into account.
New research published this month in the Southern Economic Journal reveals job losses during the Great Recession (2007-2009) may be partly responsible for the recent drop in U.S. birth rates.
Tetraphase Pharmaceuticals, a clinical stage biopharmaceutical company utilizing breakthrough synthetic chemistry technology to discover and develop next-generation antibiotics, today announced that it has raised $45 million in a Series C financing.
The Biotechnology and Biological Sciences Research Council (BBSRC) has awarded a grant of over £0.5 million to groups in the Laboratories for Integrative Neuroscience and Endocrinology and the MRC Centre for Synaptic Plasticity (project leader, Professor Kei Cho). The funding will support research into how brain cells maintain their performance, and create memories, during periods of acute stress.
› Verified 6 days ago
| Entity Name | Griffin Faculty Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
A team of researchers from Harvard School of Public Health (HSPH), Brigham and Women's Hospital (BWH), and elsewhere have described a possible reason why some studies have been unable to replicate associations between genes and traits - namely that the strength of a gene/trait association might vary with age and that current study designs typically fail to take that into account.
New research published this month in the Southern Economic Journal reveals job losses during the Great Recession (2007-2009) may be partly responsible for the recent drop in U.S. birth rates.
Tetraphase Pharmaceuticals, a clinical stage biopharmaceutical company utilizing breakthrough synthetic chemistry technology to discover and develop next-generation antibiotics, today announced that it has raised $45 million in a Series C financing.
The Biotechnology and Biological Sciences Research Council (BBSRC) has awarded a grant of over £0.5 million to groups in the Laboratories for Integrative Neuroscience and Endocrinology and the MRC Centre for Synaptic Plasticity (project leader, Professor Kei Cho). The funding will support research into how brain cells maintain their performance, and create memories, during periods of acute stress.
› Verified 6 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
A team of researchers from Harvard School of Public Health (HSPH), Brigham and Women's Hospital (BWH), and elsewhere have described a possible reason why some studies have been unable to replicate associations between genes and traits - namely that the strength of a gene/trait association might vary with age and that current study designs typically fail to take that into account.
New research published this month in the Southern Economic Journal reveals job losses during the Great Recession (2007-2009) may be partly responsible for the recent drop in U.S. birth rates.
Tetraphase Pharmaceuticals, a clinical stage biopharmaceutical company utilizing breakthrough synthetic chemistry technology to discover and develop next-generation antibiotics, today announced that it has raised $45 million in a Series C financing.
The Biotechnology and Biological Sciences Research Council (BBSRC) has awarded a grant of over £0.5 million to groups in the Laboratories for Integrative Neuroscience and Endocrinology and the MRC Centre for Synaptic Plasticity (project leader, Professor Kei Cho). The funding will support research into how brain cells maintain their performance, and create memories, during periods of acute stress.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Howard Siev, MD 20 York St, New Haven, CT 06510-3220 Ph: (203) 688-4242 | Michael Howard Siev, MD 20 York St, New Haven, CT 06510-3220 Ph: (203) 688-4242 |
News Archive
A team of researchers from Harvard School of Public Health (HSPH), Brigham and Women's Hospital (BWH), and elsewhere have described a possible reason why some studies have been unable to replicate associations between genes and traits - namely that the strength of a gene/trait association might vary with age and that current study designs typically fail to take that into account.
New research published this month in the Southern Economic Journal reveals job losses during the Great Recession (2007-2009) may be partly responsible for the recent drop in U.S. birth rates.
Tetraphase Pharmaceuticals, a clinical stage biopharmaceutical company utilizing breakthrough synthetic chemistry technology to discover and develop next-generation antibiotics, today announced that it has raised $45 million in a Series C financing.
The Biotechnology and Biological Sciences Research Council (BBSRC) has awarded a grant of over £0.5 million to groups in the Laboratories for Integrative Neuroscience and Endocrinology and the MRC Centre for Synaptic Plasticity (project leader, Professor Kei Cho). The funding will support research into how brain cells maintain their performance, and create memories, during periods of acute stress.
› Verified 6 days ago
Dr. Thomas V. Martin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 330 Orchard St, Suite 164, New Haven, CT 06511 Phone: 203-789-2222 Fax: 203-624-3697 | |
John W Colberg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building 3rd Floor, New Haven, CT 06519 Phone: 203-785-2815 Fax: 203-785-4043 | |
Harris E Foster Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Avenue #318, New Haven, CT 06520 Phone: 203-785-2815 Fax: 203-785-4043 | |
Dr. Gregory Lamont Lacy Ii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, New Haven, CT 06519 Phone: 203-785-2815 Fax: 203-785-4043 | |
Ralph J Devito, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 330 Orchard St, Suite 164, New Haven, CT 06511 Phone: 203-789-2222 Fax: 203-624-3697 | |
Dr. Israel Franco, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 789 Howard Avenue,, Fmp 300, New Haven, CT 06520 Phone: 203-785-7671 |